Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600116007) titled 'Efficacy and Safety of an IL-1 Inhibitor in the Perioperative Period of Patients Undergoing Tophus Resection: A Single-Center, Prospective, Randomized, Positive-Controlled Study' on Jan. 4.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Fifth Hospital of Xi'an
Condition:
Gouty Arthritis
Intervention:
Experimental Group:Preoperatively, 200 mg of Vunakizumab was administered subcutaneously, along with daily oral colchicine 0.5 mg.
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-01-10
Target Sample Size: Experimental Group:27;Control Group:27;
...